Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
US-2015025082-A1 · Jan 22, 2015 · US
Liquid preparation comprising pimobendan
US9107952B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9107952-B2 |
| Application number | US-93512907-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 5, 2007 |
| Priority date | Nov 7, 2006 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to novel liquid preparation comprising a substituted benzimidazol, preferably pimobendan as pharmaceutically active compound. In particular, the present invention relates to liquid preparation comprising an etherified cyclodextrin derivative, preferably in a concentration of about 20 to 70% (w/v) and said substituted benzimidazol, preferably in a concentration of about 0.005 to 0.15% (w/w).
First claim
Opening claim text (preview).
The invention claimed is: 1. A liquid preparation comprising: about 20 to 30% (w/v) of an etherified cyclodextrin derivative selected from the group consisting of alpha-, beta- and gamma-cyclodextrin ethers; and about 0.075 to 0.1% (w/v) of pimobendan or a pharmaceutically acceptable salt thereof, wherein the molar ratio of pimobendan or the pharmaceutically acceptable salt thereof to the etherified cyclodextrin derivative is about 1:47 to about 1:96. 2. Th…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9107952B2 cover?
- The invention relates to novel liquid preparation comprising a substituted benzimidazol, preferably pimobendan as pharmaceutically active compound. In particular, the present invention relates to liquid preparation comprising an etherified cyclodextrin derivative, preferably in a concentration of about 20 to 70% (w/v) and said substituted benzimidazol, preferably in a concentration of about 0.0…
- Who is the assignee on this patent?
- Folger Martin, Lehner Stefan, Boehringer Ingelheim Vetmed
- What technology area does this patent fall under?
- Primary CPC classification A61K9/08. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).